SALT LAKE CITY, Utah — Rejuvatek Medical Inc, officially announces that Dr. Jeffery L. Deal has agreed to serve as Medical Director for the company’s revolutionary Tatt2Away (www.tatt2away.com) non-laser tattoo removal system. In this important role, Dr. Deal will review new technologies and advise the Rejuvatek Medical team on product development and implementation, providing expertise on matters benefiting from his clinical knowledge.
“Jeff is a unique blend of clinical, scientific and entrepreneurial talent. Having witnessed his many accomplishments over the years, I am beyond excited that he has joined our team,” says Rejuvatek Medical CEO Jack Savage. “Jeff’s advice and insight will take our already strong team to a new level.”
“The Tatt2Away team consists of management with decades of experience bringing healthcare products safely to market; talented bio-engineers, physicists, tattoo artists, and social media experts,” said Dr. Deal. “My addition is knowledge and experience in surgical wound care, experience in regulatory matters, as well as experience in research and development of products with an emphasis on patient safety.”
Dr. Deal has had a distinguished medical career including 30 years as a clinical instructor at the Medical University of South Carolina. He holds degrees from seven universities, three earned fellowships, and board certification in two fields of medicine.
“The Tatt2Away team consists of management with decades of experience bringing healthcare products safely to market; talented bio-engineers, physicists, tattoo artists, social media experts,” Dr. Deal says. “My addition is knowledge and experience in surgical wound care, experience in regulatory matters, as well as experience in research and development of products with an emphasis on patient safety.”
Along with extensive experience in health care settings, Dr. Deal has a passion for furthering medical education and technologies. He has published on the subject of microbiology, surgery, tropical diseases, anthropology, and bioethics, and is the inventor of TRU-D SmartUVC, an automated UVC disinfection robot used to eliminate pathogens in health care environments. Hundreds of TRU-Ds have been deployed to disinfect hospitals across the U.S., Canada, Europe and Africa.
“I enjoy living in the learning curve. Tatt2Away is dramatically different than any other endeavor I have taken, and I find it stimulating,” Dr. Deal says.
“For years, I have had concerns regarding the long term impact of tattoo ink on human health, and what intrigued me about Tatt2Away is that it is a true ‘removal’ process as opposed to laser procedures which simply break up the pigments into smaller particles that are then absorbed into a person’s system,” Dr. Deal adds. “There are troubling suggestions in the literature, especially from Europe, that these altered particles carry long term risks. Tatt2Away actually removes the tattoo pigment from the client’s skin — this is BIG.”
For more of Dr. Deal’s insights into tattoo removal, visit: http://tatt2away.com/news-articles/tatt2away-adds-medical-director-tattoo-removal-team/.
ABOUT REJUVATEK MEDICAL / TATT2AWAY:
Rejuvatek Medical, manufacturer of the Tatt2Away(R) Tattoo Removal System, specializes in the development of natural and effective tattoo removal options for the tattoo removal industry. Tatt2Away(R) utilizes a proprietary “Trans-Epidermal Pigment Release(R)” (TEPR(R)) system, which extracts ink out of the body, thus avoiding potential health risks associated with laser removal.
More information: http://www.tatt2away.com/.
This news story was published by the Neotrope® News Network – all rights reserved.